Article

Population immunity to pre-Omicron and Omicron SARS-CoV-2 variants in US states and counties through December 1, 2021

2021-12-24

Abstract excerpt

Prior infection and vaccination both contribute to population-level SARS-CoV-2 immunity. We used a Bayesian model to synthesize evidence and estimate population immunity to prevalent SARS-CoV-2 variants in the United States over the course of the epidemic until December 1, 2021, and how this changed with the introduction of the Omicron variant. We used daily SARS-CoV-2 infection estimates and vaccination coverage...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 190dfc54-b06b-54cd-91ce-e34c2da02bfd
DOI: 10.1101/2021.12.23.21268272

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Population immunity to pre-Omicron and Omicron SARS-CoV-2 variants in US states and counties through December 1, 2021DOI 10.1101/2021.12.23.21268272Read

Changes in population immunity against infection and severe disease from SARS-CoV-2 Omicron variants in the United States between December 2021 and November 2022Semantic proximity Read

National- and state-level SARS-CoV-2 immunity trends from January 2020 to December 2023: a mathematical modeling analysisSemantic proximity Read

Estimates of presumed population immunity to SARS-CoV-2 by state in the United States, August 2021Semantic proximity Read

Impact of Vaccination, Prior Infection, and Therapy on Delta and Omicron VariantsSemantic proximity Read

Protective effectiveness of prior SARS-CoV-2 infection and hybrid immunity against Omicron infection and severe disease: a systematic review and meta-regressionSemantic proximity Read

SARS-CoV-2 attack rate and population immunity in southern New England, March 2020 - May 2021Semantic proximity Read

Behaviour, booster vaccines and waning immunity: modelling the medium-term dynamics of SARS-CoV-2 transmission in England in the Omicron eraSemantic proximity Read

Risk of SARS-CoV-2 Infection and Hospitalization in Individuals with Natural, Vaccine-Induced and Hybrid Immunity: A Retrospective Nationwide Study from EstoniaSemantic proximity Read

The potential impact of Omicron and future variants of concern on SARS-CoV-2 transmission dynamics and public health burden: a modelling studySemantic proximity Read

Waning of SARS-CoV-2 vaccine-induced immunity: A systematic review and secondary data analysisSemantic proximity Read

Protection against symptomatic disease with the delta and omicron BA.1/BA.2 variants of SARS-CoV-2 after infection and vaccination in adolescents: national observational test-negative case control study, August 2021 to March 2022, EnglandSemantic proximity Read

Prior SARS-CoV-2 Infection and COVID-19 Vaccine Effectiveness against Outpatient Illness during Widespread Circulation of SARS-CoV-2 Omicron Variant, US Flu VE NetworkSemantic proximity Read